Moolec Science SAMLECEarnings & Financial Report
Moolec Science SA is a global agricultural biotechnology and food technology company specializing in molecular farming. It uses engineered crop platforms to produce sustainable, cost-competitive animal-derived proteins for use in alternative meat, dairy products and food ingredients, serving food manufacturers, agribusinesses and consumer goods brands across North America, Europe and Latin America.
Revenue
$1.7M
Gross Profit
$220.4K
Operating Profit
$-2.3M
Net Profit
$-1.6M
Gross Margin
12.7%
Operating Margin
-130.3%
Net Margin
-91.4%
YoY Growth
N/A
EPS
$-0.04
Financial Flow
Moolec Science SA Q1 2024 Financial Summary
Moolec Science SA reported revenue of $1.7M for Q1 2024, with a net profit of $-1.6M (-91.4% margin). Cost of goods sold was $1.5M, operating expenses totaled $2.5M.
Key Financial Metrics
| Total Revenue | $1.7M |
|---|---|
| Net Profit | $-1.6M |
| Gross Margin | 12.7% |
| Operating Margin | -130.3% |
| Report Period | Q1 2024 |
Moolec Science SA Quarterly Revenue & Net Profit History
Moolec Science SA results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 2025 | $2.6M | — | $-2.4M | -91.8% |
| Q1 2024 | $1.7M | — | $-1.6M | -91.4% |
Income Statement
| Q1 2024 | Q2 2025 | |
|---|---|---|
| Revenue | $1.7M | $2.6M |
| YoY Growth | N/A | N/A |
Balance Sheet
| Q1 2024 | Q2 2025 | |
|---|---|---|
| Assets | $22.5M | $31.4M |
| Liabilities | $13.6M | $28.6M |
| Equity | $8.9M | $2.8M |
Cash Flow
| Q1 2024 | |
|---|---|
| Operating CF | $-1.7M |